| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | foretinib | CTRPv2 | pan-cancer | AAC | -0.029 | 0.4 |
| mRNA | PF-750 | CTRPv2 | pan-cancer | AAC | 0.032 | 0.4 |
| mRNA | selumetinib:UNC0638 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.029 | 0.4 |
| mRNA | BRD-K45681478 | CTRPv2 | pan-cancer | AAC | -0.029 | 0.4 |
| mRNA | PRIMA-1-Met | CTRPv2 | pan-cancer | AAC | -0.043 | 0.4 |
| mRNA | cabozantinib | CTRPv2 | pan-cancer | AAC | -0.03 | 0.4 |
| mRNA | Rapamycin | gCSI | pan-cancer | AAC | -0.044 | 0.4 |
| mRNA | COL-3 | CTRPv2 | pan-cancer | AAC | 0.03 | 0.4 |
| mRNA | OSI-930 | CTRPv2 | pan-cancer | AAC | 0.029 | 0.4 |
| mRNA | alvocidib | CTRPv2 | pan-cancer | AAC | 0.039 | 0.4 |